Skip to content
10-Q/A

Quarterly Report

CTT PHARMACEUTICAL HOLDINGS, INC. CTTH

0001553350-15-001258

← back to feed
Filed
Nov 18, 2015 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2015 · Nov 10, 2015 21.35M sh
Operating Cash Flow Q2 2015 · Jun 30, 2015 −$68.81K
Operating Cash Flow restated Q2 2015 · Jun 30, 2014 −$1.21K
Cash And Equivalents Q2 2015 · Jun 30, 2015 $46.07K
Cash And Equivalents Q2 2015 · Dec 31, 2014 $81.18K
Cash And Equivalents restated Q2 2015 · Jun 30, 2014 $3.67K
Stockholders Equity restated Q2 2015 · Jun 30, 2015 $1.03M
Stockholders Equity restated Q2 2015 · Dec 31, 2014 $1.49M
Stockholders Equity restated Q2 2015 · Dec 31, 2013 −$29.32K
Stockholders Equity restated Q2 2015 · Dec 31, 2012 −$20K
Total Liabilities restated Q2 2015 · Jun 30, 2015 $156.37K
Total Liabilities restated Q2 2015 · Dec 31, 2014 $169.49K
Current Assets Q2 2015 · Jun 30, 2015 $958.69K
Current Assets Q2 2015 · Dec 31, 2014 $1.05M
Total Assets Q2 2015 · Jun 30, 2015 $1.18M
Total Assets Q2 2015 · Dec 31, 2014 $1.66M
Sga Expense Q2 2015 · Jun 30, 2015 $4.47K
Sga Expense Q2 2015 · Jun 30, 2015 $39.35K
Sga Expense restated Q2 2015 · Jun 30, 2014 $916
Sga Expense restated Q2 2015 · Jun 30, 2014 $1.82K
Net Income Q2 2015 · Jun 30, 2015 −$362.66K
Net Income Q2 2015 · Jun 30, 2015 −$699.71K
Net Income restated Q2 2015 · Dec 31, 2014 −$672.16K
Net Income restated Q2 2015 · Jun 30, 2014 −$920
Net Income restated Q2 2015 · Jun 30, 2014 −$2.59K
Net Income Q2 2015 · Dec 31, 2013 −$18.91K